Staged Kidney Transplantation During Combined Heart/Kidney Transplantation

Description

The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.

Conditions

Heart Failure, Chronic Kidney Disease, End-stage Kidney Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.

Staged Kidney Transplantation During Combined Heart/Kidney Transplantation

Staged Kidney Transplantation During Combined Heart/Kidney Transplantation

Condition
Heart Failure
Intervention / Treatment

-

Contacts and Locations

Los Angeles

Cedars-Sinai Medical Center, Los Angeles, California, United States, 90048

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult patients (18 years or older) undergoing combined heart and kidney transplantation at Cedars-Sinai Medical Center.
  • * Patients who undergo simultaneous heart/kidney transplantation in a single operative event due to medical necessity will be excluded.
  • * Patients with medical records flagged as "break-the-glass" or "research opt-out" within the center's electronic health record.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Cedars-Sinai Medical Center,

Justin A Steggerda, M.D., PRINCIPAL_INVESTIGATOR, Cedars-Sinai Medical Center

Study Record Dates

2035-02-28